Trough plasma levels of imatinib have been associated with both cytogenetic and molecular responses, with a level of around 1000 ng/mL recommended for a full molecular response.1 However, at a given dose, trough plasma levels of imatinib may vary greatly between patients. There are several potential causes, including pharmacokinetic factors such as drug–drug interactions, and patient-related factors such as adherence. Hence, if a patient is not responding to imatinib as expected, blood-level testing is an essential tool for determining whether imatinib blood levels are adequate.
It should not be assumed that the patient has become resistant to imatinib. More.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.